Member Info for PipeDragger

Late year it was Q1 2017, then H1 2017, now it is "late 2017" for clinical trials. These things always take longer than expected. When it happens it should trigger value growth but only the successful end of clinical trials is where original investors might see their money back or even a bit of profit. Maybe late 2018. Patience all. (I am glad I didn't buy at the original launch price)

On one hand they were overly ambitious and ran out of money so most of the workforce had to go .... but on the other hand the products they had already discovered have such a high potential value (clinical and monetary) that they have easily raised new money and had a major grant. There is plenty of cash in the piggy bank now and they say they are re-focused on getting the trials started. It might easily be another year before the original investors see the share price recover to the level when the company launched, never mind a profit. Some news of clinical trial starts would really help!

Not right anymore! I wonder how low it will go. I suppose it will keep dropping until there is some news on clinical trials.

The price today is just above the recent placing. That is fine for me!

The funding news today breaks that downward drift a little! Another year and it should all look much better.

I was looking back on the older RNS: 19th Sept: "......As previously reported, first-in-human studies for the Porcupine inhibitor, initially as a stand-alone therapy, are expected to commence early in 2017.......". In-human studies doesn't seem to have happened - I am sure that explains all as regards current price. We hope it will come good in the end (as long as they don't run out of cash again!).

I think some people know (or maybe guessing) when the results will be out and so are today buying up in anticipation of a jump. Would be nice for us shareholders to know that date.

It is a non-announcement. I think there is something rather serious going on in the background....... good or bad is just guess work.

The annual results are overdue - one wonders what is going on? Could be good or bad but there is just nothing to work with. (Good news we hope)